These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 19546529)

  • 21. Associations of lipoprotein lipase S447X and apolipoprotein E genotypes with low-density lipoprotein subfractions in Turkish patients with coronary artery disease.
    Aydogan HY; Isbir S; Kurnaz O; Gormus U; Isbir T
    In Vivo; 2009; 23(1):155-61. PubMed ID: 19368142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol.
    DeFaria Yeh D; Freeman MW; Meigs JB; Grant RW
    Am J Cardiol; 2007 Jan; 99(1):1-4. PubMed ID: 17196452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sialic acid content of low-density lipoprotein in women with coronary artery disease.
    Lindbohm N; Gylling H; Rajaratnam RA; Miettinen TA
    J Lab Clin Med; 2000 Aug; 136(2):110-5. PubMed ID: 10945239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-density lipoprotein (LDL), which includes apolipoprotein A-I (apoAI-LDL) as a novel marker of coronary artery disease.
    Ogasawara K; Mashiba S; Hashimoto H; Kojima S; Matsuno S; Takeya M; Uchida K; Yajima J
    Clin Chim Acta; 2008 Nov; 397(1-2):42-7. PubMed ID: 18691566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of antibodies to oxidized low-density lipoprotein and assessment of C-reactive protein in acute coronary syndrome and stable coronary artery disease.
    Soltesz P; Veres K; Laczik R; Der H; Csipo I; Timar O; Szomjak E; Szegedi G; Szodoray P
    Thromb Haemost; 2007 Aug; 98(2):413-9. PubMed ID: 17721625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study on serum oxidized low density lipoprotein and anti-oxidized competence in patient with coronary heart disease].
    Li GX; Li P
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):690-2. PubMed ID: 15460421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Association between plasma adiponectin and small, dense low density lipoprotein in patients with coronary artery disease].
    Chen G; Qin Q; Li Y; Ren B; Lu YR; Kou L; Yang N; Feng JP; Zhao BR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Sep; 40(9):752-6. PubMed ID: 23141087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidized-LDL/beta(2)-glycoprotein I complexes are associated with disease severity and increased risk for adverse outcomes in patients with acute coronary syndromes.
    Greco TP; Conti-Kelly AM; Anthony JR; Greco T; Doyle R; Boisen M; Kojima K; Matsuura E; Lopez LR
    Am J Clin Pathol; 2010 May; 133(5):737-43. PubMed ID: 20395520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of small dense low-density lipoprotein as a risk factor for coronary artery disease and acute coronary syndrome.
    Kwon SW; Yoon SJ; Kang TS; Kwon HM; Kim JH; Rhee J; Lee SJ; Park JK; Lim JY; Yoon YW; Hong BK
    Yonsei Med J; 2006 Jun; 47(3):405-14. PubMed ID: 16807992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Oxidized LDL in patients with coronary heart disease and normal subjects].
    Hasegawa A; Toshima S; Nakano A; Nagai R
    Nihon Rinsho; 1999 Dec; 57(12):2754-8. PubMed ID: 10638208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Lipid peroxidation and LDL modifications in nondiabetic patients with ischemic heart disease: the role of insulin action].
    Avogaro A; Armigliato M; Cazzolato G; Caruso N; Boffa G; Bittolo Bon G; Tiengo A
    G Ital Cardiol; 1996 Feb; 26(2):169-75. PubMed ID: 8666174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein C-III Levels and Incident Coronary Artery Disease Risk: The EPIC-Norfolk Prospective Population Study.
    van Capelleveen JC; Bernelot Moens SJ; Yang X; Kastelein JJP; Wareham NJ; Zwinderman AH; Stroes ESG; Witztum JL; Hovingh GK; Khaw KT; Boekholdt SM; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1206-1212. PubMed ID: 28473441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated plasma myeloperoxidase levels in relation to circulating inflammatory markers in coronary artery disease.
    Samsamshariat SZ; Basati G; Movahedian A; Pourfarzam M; Sarrafzadegan N
    Biomark Med; 2011 Jun; 5(3):377-85. PubMed ID: 21657847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of small dense low-density lipoprotein-cholesterol concentrations in relation to the severity of coronary heart diseases.
    Koba S; Hirano T; Ito Y; Tsunoda F; Yokota Y; Ban Y; Iso Y; Suzuki H; Katagiri T
    Atherosclerosis; 2006 Nov; 189(1):206-14. PubMed ID: 16414053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FADS gene polymorphisms in Koreans: association with ω6 polyunsaturated fatty acids in serum phospholipids, lipid peroxides, and coronary artery disease.
    Kwak JH; Paik JK; Kim OY; Jang Y; Lee SH; Ordovas JM; Lee JH
    Atherosclerosis; 2011 Jan; 214(1):94-100. PubMed ID: 21040914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of lifestyle modification on oxidized LDL, reactive oxygen species production and endothelial cell viability in patients with coronary artery disease.
    Srimahachota S; Wunsuwan R; Siritantikorn A; Boonla C; Chaiwongkarjohn S; Tosukhowong P
    Clin Biochem; 2010 Jul; 43(10-11):858-62. PubMed ID: 20416290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein(a) and LDL particle size are related to the severity of coronary artery disease.
    Moon JY; Kwon HM; Kwon SW; Yoon SJ; Kim JS; Lee SJ; Park JK; Rhee JH; Yoon YW; Hong BK; Rim SJ; Kim HS
    Cardiology; 2007; 108(4):282-9. PubMed ID: 17284906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small dense LDL: An emerging risk factor for cardiovascular disease.
    Hirayama S; Miida T
    Clin Chim Acta; 2012 Dec; 414():215-24. PubMed ID: 22989852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of Serum Levels of Inflammation, Fibrinolysis and Oxidative Stress Markers in Coronary Artery Disease Prediction: A Cross-Sectional Study.
    Abolhasani S; Shahbazloo SV; Saadati HM; Mahmoodi N; Khanbabaei N
    Arq Bras Cardiol; 2019; 113(4):667-674. PubMed ID: 31482948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.